Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
15 Febbraio 2024 - 1:00PM
Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company
will host a conference call and live audio webcast on Wednesday,
February 28, 2024, at 8:30 a.m. ET to discuss financial results for
the full-year ended December 31, 2023.
Participants and investors interested in
accessing the call by phone will need to register using the online
registration form. After registering, all phone participants will
receive a dial-in number along with a personal PIN to access the
event. A live audio webcast and related presentation materials can
also be accessed via the Investors section of the Amicus
Therapeutics corporate website at ir.amicusrx.com. Web participants
are encouraged to register on the website 15 minutes prior to the
start of the call.
An archived webcast and accompanying slides will
be available on the Company's website shortly after the conclusion
of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
diseases. With extraordinary patient focus, Amicus Therapeutics is
committed to advancing and expanding a pipeline of cutting-edge,
first- or best-in-class medicines for rare diseases. For more
information please visit the company’s website at www.amicusrx.com,
and follow on Twitter and LinkedIn.
CONTACT:
Investors:Amicus
TherapeuticsAndrew FaughnanVice President, Investor
Relationsafaughnan@amicusrx.com (609) 662-3809
Media:Amicus TherapeuticsDiana
MooreHead of Global Corporate Affairs and
Communicationsdmoore@amicusrx.com (609) 662-5079
FOLD–G
Grafico Azioni Amicus Therapeutics (NASDAQ:FOLD)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Amicus Therapeutics (NASDAQ:FOLD)
Storico
Da Mag 2023 a Mag 2024